Quality e-Newsletter
Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

One big antibiotic dose fights MRSA, study says

Wall Street Journal (subscription required), October 22, 2008

Powerful antibiotic drugs are normally injected once a day—a problem for patients who contract infections in hospital wards and are sent home. But a new study found that an experimental antibiotic may work just as well when given in one gigantic dose, marking progress in the treatment of drug-resistant infections, including MRSA. The research was conducted by Targanta Therapeutics Corp., a company that has applied to sell the antibiotic, oritavancin, in the U.S.